ID   SRC_HUMAN               Reviewed;         536 AA.
AC   P12931; Q76P87; Q86VB9; Q9H5A8;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   05-OCT-2010, entry version 144.
DE   RecName: Full=Proto-oncogene tyrosine-protein kinase Src;
DE            EC=2.7.10.2;
DE   AltName: Full=Proto-oncogene c-Src;
DE   AltName: Full=pp60c-src;
DE            Short=p60-Src;
GN   Name=SRC; Synonyms=SRC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21638749; PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-185 (ISOFORM 1).
RX   MEDLINE=87257903; PubMed=3299057;
RA   Tanaka A., Gibbs C.P., Arthur R.R., Anderson S.K., Kung H.-J.,
RA   Fujita D.J.;
RT   "DNA sequence encoding the amino-terminal region of the human c-src
RT   protein: implications of sequence divergence among src-type kinase
RT   oncogenes.";
RL   Mol. Cell. Biol. 7:1978-1983(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 186-536 (ISOFORM 1).
RX   MEDLINE=85213483; PubMed=2582238;
RA   Anderson S.K., Gibbs C.P., Tanaka A., Kung H.-J., Fujita D.J.;
RT   "Human cellular src gene: nucleotide sequence and derived amino acid
RT   sequence of the region coding for the carboxy-terminal two-thirds of
RT   pp60c-src.";
RL   Mol. Cell. Biol. 5:1122-1129(1985).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 98-139 (ISOFORM 2).
RX   MEDLINE=90040822; PubMed=2681803; DOI=10.1002/jnr.490240113;
RA   Pyper J.M., Bolen J.B.;
RT   "Neuron-specific splicing of C-SRC RNA in human brain.";
RL   J. Neurosci. Res. 24:89-96(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 376-536 (ISOFORM 1).
RX   MEDLINE=85187981; PubMed=2581127;
RA   Parker R.C., Mardon G., Lebo R.V., Varmus H.E., Bishop J.M.;
RT   "Isolation of duplicated human c-src genes located on chromosomes 1
RT   and 20.";
RL   Mol. Cell. Biol. 5:831-838(1985).
RN   [8]
RP   ALTERNATIVE SPLICING.
RX   PubMed=1691439;
RA   Pyper J.M., Bolen J.B.;
RT   "Identification of a novel neuronal C-SRC exon expressed in human
RT   brain.";
RL   Mol. Cell. Biol. 10:2035-2040(1990).
RN   [9]
RP   INTERACTION WITH ADRB2 AND ARRB1.
RX   PubMed=9924018; DOI=10.1126/science.283.5402.655;
RA   Luttrell L.M., Ferguson S.S.G., Daaka Y., Miller W.E., Maudsley S.,
RA   Della Rocca G.J., Lin F.-T., Kawakatsu H., Owada K., Luttrell D.K.,
RA   Caron M.G., Lefkowitz R.J.;
RT   "Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src
RT   protein kinase complexes.";
RL   Science 283:655-661(1999).
RN   [10]
RP   INTERACTION WITH ARRB1 AND ARRB2.
RX   PubMed=10753943; DOI=10.1074/jbc.275.15.11312;
RA   Miller W.E., Maudsley S., Ahn S., Khan K.D., Luttrell L.M.,
RA   Lefkowitz R.J.;
RT   "beta-arrestin1 interacts with the catalytic domain of the tyrosine
RT   kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in
RT   receptor endocytosis.";
RL   J. Biol. Chem. 275:11312-11319(2000).
RN   [11]
RP   INTERACTION WITH RALGPS1.
RX   MEDLINE=20250892; PubMed=10747847; DOI=10.1074/jbc.C000085200;
RA   Rebhun J.F., Chen H., Quilliam L.A.;
RT   "Identification and characterization of a new family of guanine
RT   nucleotide exchange factors for the ras-related GTPase Ral.";
RL   J. Biol. Chem. 275:13406-13410(2000).
RN   [12]
RP   INTERACTION WITH MUC1.
RX   PubMed=11152665; DOI=10.1074/jbc.C000754200;
RA   Li Y., Kuwahara H., Ren J., Wen G., Kufe D.;
RT   "The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1
RT   carcinoma-associated antigen with GSK3 beta and beta-catenin.";
RL   J. Biol. Chem. 276:6061-6064(2001).
RN   [13]
RP   INTERACTION WITH HEV ORF3 PROTEIN.
RX   PubMed=11518702; DOI=10.1074/jbc.M101546200;
RA   Korkaya H., Jameel S., Gupta D., Tyagi S., Kumar R., Zafrullah M.,
RA   Mazumdar M., Lal S.K., Xiaofang L., Sehgal D., Das S.R., Sahal D.;
RT   "The ORF3 protein of hepatitis E virus binds to Src homology 3 domains
RT   and activates MAPK.";
RL   J. Biol. Chem. 276:42389-42400(2001).
RN   [14]
RP   INTERACTION WITH CAV2.
RX   MEDLINE=22206546; PubMed=12091389; DOI=10.1074/jbc.M204367200;
RA   Lee H., Park D.S., Wang X.B., Scherer P.E., Schwartz P.E.,
RA   Lisanti M.P.;
RT   "Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-
RT   caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains
RT   associated with lipid rafts/caveolae, but no longer forms a high
RT   molecular mass hetero-oligomer with caveolin-1.";
RL   J. Biol. Chem. 277:34556-34567(2002).
RN   [15]
RP   INTERACTION WITH PELP1.
RX   MEDLINE=22317447; PubMed=12415108; DOI=10.1073/pnas.192569699;
RA   Wong C.-W., McNally C., Nickbarg E., Komm B.S., Cheskis B.J.;
RT   "Estrogen receptor-interacting protein that modulates its nongenomic
RT   activity-crosstalk with Src/Erk phosphorylation cascade.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14783-14788(2002).
RN   [16]
RP   INTERACTION WITH CAV2.
RX   PubMed=15504032; DOI=10.1021/bi049295+;
RA   Wang X.B., Lee H., Capozza F., Marmon S., Sotgia F., Brooks J.W.,
RA   Campos-Gonzalez R., Lisanti M.P.;
RT   "Tyrosine phosphorylation of caveolin-2 at residue 27: differences in
RT   the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).";
RL   Biochemistry 43:13694-13706(2004).
RN   [17]
RP   INTERACTION WITH CDCP1.
RX   PubMed=15851033; DOI=10.1016/j.cell.2005.02.019;
RA   Benes C.H., Wu N., Elia A.E.H., Dharia T., Cantley L.C., Soltoff S.P.;
RT   "The C2 domain of PKCdelta is a phosphotyrosine binding domain.";
RL   Cell 121:271-280(2005).
RN   [18]
RP   INTERACTION WITH TOM1L2.
RX   PubMed=16479011; DOI=10.1128/MCB.26.5.1932-1947.2006;
RA   Franco M., Furstoss O., Simon V., Benistant C., Hong W.J., Roche S.;
RT   "The adaptor protein Tom1L1 is a negative regulator of Src mitogenic
RT   signaling induced by growth factors.";
RL   Mol. Cell. Biol. 26:1932-1947(2006).
RN   [19]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=17202804; DOI=10.1159/000098402;
RA   Maudsley S., Davidson L., Pawson A.J., Freestone S.H.,
RA   Lopez de Maturana R., Thomson A.A., Millar R.P.;
RT   "Gonadotropin-releasing hormone functionally antagonizes testosterone
RT   activation of the human androgen receptor in prostate cells through
RT   focal adhesion complexes involving Hic-5.";
RL   Neuroendocrinology 84:285-300(2006).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-439, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [21]
RP   INTERACTION WITH SRCIN1.
RX   PubMed=17525734; DOI=10.1038/sj.emboj.7601724;
RA   Di Stefano P., Damiano L., Cabodi S., Aramu S., Tordella L.,
RA   Praduroux A., Piva R., Cavallo F., Forni G., Silengo L., Tarone G.,
RA   Turco E., Defilippi P.;
RT   "p140Cap protein suppresses tumour cell properties, regulating Csk and
RT   Src kinase activity.";
RL   EMBO J. 26:2843-2855(2007).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-69; SER-75 AND
RP   TYR-419, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; THR-74 AND TYR-419,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-530, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-35; SER-69;
RP   THR-74; SER-75; THR-511; TYR-522 AND TYR-530, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [27]
RP   INTERACTION WITH NDFIP1 AND NDFIP2.
RX   PubMed=20534535; DOI=10.1073/pnas.0911714107;
RA   Mund T., Pelham H.R.;
RT   "Regulation of PTEN/Akt and MAP kinase signaling pathways by the
RT   ubiquitin ligase activators Ndfip1 and Ndfip2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:11429-11434(2010).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 86-536.
RX   MEDLINE=97177105; PubMed=9024657; DOI=10.1038/385595a0;
RA   Xu W., Harrison S.C., Eck M.J.;
RT   "Three-dimensional structure of the tyrosine kinase c-Src.";
RL   Nature 385:595-602(1997).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 145-249.
RX   MEDLINE=97317069; PubMed=9174343; DOI=10.1021/bi970019n;
RA   Charifson P.S., Shewchuk L.M., Rocque W., Hummel C.W., Jordan S.R.,
RA   Mohr C., Pacofsky G.J., Peel M.R., Rodriguez M., Sternbach D.D.,
RA   Consler T.G.;
RT   "Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and
RT   structural study.";
RL   Biochemistry 36:6283-6293(1997).
RN   [30]
RP   STRUCTURE BY NMR OF 204-249.
RX   MEDLINE=95161382; PubMed=7532003; DOI=10.1021/bi00007a003;
RA   Xu R.X., Word J.M., Davis D.G., Rink M.J., Willard D.H. Jr.,
RA   Gampe R.T. Jr.;
RT   "Solution structure of the human pp60c-src SH2 domain complexed with a
RT   phosphorylated tyrosine pentapeptide.";
RL   Biochemistry 34:2107-2121(1995).
RN   [31]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-237.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with DDEF1/ASAP1; via the SH3 domain. Interacts
CC       with CCPG1 (By similarity). Interacts with CDCP1, PELP1, TGFB1I1
CC       and TOM1L2. Interacts with the cytoplasmic domain of MUC1,
CC       phosphorylates it and increases binding of MUC1 with beta-catenin.
CC       Interacts with RALGPS1; via the SH3 domain. Interacts with HEV
CC       ORF3 protein; via the SH3 domain. Interacts with CAV2 (tyrosine
CC       phosphorylated form). Interacts (via the SH3 domain and the
CC       protein kinase domain) with ARRB1; the interaction is independent
CC       of the phosphorylation state of SRC C-terminus. Interacts with
CC       ARRB1 and ARRB2. Interacts with SRCIN1. Interacts with NDFIP2 and
CC       more weakly with NDFIP1.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=1; IntAct=EBI-621482, EBI-375543;
CC       P42684:ABL2; NbExp=1; IntAct=EBI-621482, EBI-1102694;
CC       Q15027:ACAP1; NbExp=1; IntAct=EBI-621482, EBI-751746;
CC       P12814:ACTN1; NbExp=2; IntAct=EBI-621482, EBI-351710;
CC       O43918:AIRE; NbExp=1; IntAct=EBI-621482, EBI-1753081;
CC       Q9Y2D5:AKAP2; NbExp=1; IntAct=EBI-621482, EBI-1754555;
CC       Q13023:AKAP6; NbExp=1; IntAct=EBI-621482, EBI-1056102;
CC       Q96Q35:ALS2CR12; NbExp=1; IntAct=EBI-621482, EBI-1755548;
CC       Q9BWW9:APOL5; NbExp=1; IntAct=EBI-621482, EBI-1753592;
CC       Q8R5G7:Arap3 (xeno); NbExp=3; IntAct=EBI-621482, EBI-621463;
CC       Q9ULH1:ASAP1; NbExp=1; IntAct=EBI-621482, EBI-346622;
CC       O43150:ASAP2; NbExp=1; IntAct=EBI-621482, EBI-310968;
CC       Q96NS5:ASB16; NbExp=1; IntAct=EBI-621482, EBI-1751918;
CC       Q63767:Bcar1 (xeno); NbExp=1; IntAct=EBI-621482, EBI-1176801;
CC       P20810:CAST; NbExp=1; IntAct=EBI-621482, EBI-1268770;
CC       P48960:CD97; NbExp=1; IntAct=EBI-621482, EBI-1756009;
CC       P46527:CDKN1B; NbExp=1; IntAct=EBI-621482, EBI-519280;
CC       Q9HCU4:CELSR2; NbExp=1; IntAct=EBI-621482, EBI-724117;
CC       Q14008:CKAP5; NbExp=1; IntAct=EBI-621482, EBI-310585;
CC       Q8IWT3:CUL9; NbExp=1; IntAct=EBI-621482, EBI-311123;
CC       P78329:CYP4F2; NbExp=1; IntAct=EBI-621482, EBI-1752413;
CC       Q14118:DAG1; NbExp=1; IntAct=EBI-621482, EBI-1755945;
CC       O14490:DLGAP1; NbExp=1; IntAct=EBI-621482, EBI-1753207;
CC       Q9P1A6:DLGAP2; NbExp=1; IntAct=EBI-621482, EBI-1753397;
CC       O95886:DLGAP3; NbExp=1; IntAct=EBI-621482, EBI-1752541;
CC       Q9Y2H0:DLGAP4; NbExp=1; IntAct=EBI-621482, EBI-722139;
CC       Q92988:DLX4; NbExp=1; IntAct=EBI-621482, EBI-1752755;
CC       Q14185:DOCK1; NbExp=1; IntAct=EBI-621482, EBI-446740;
CC       Q8IZD9:DOCK3; NbExp=1; IntAct=EBI-621482, EBI-1752361;
CC       Q9H1R2:DUSP15; NbExp=1; IntAct=EBI-621482, EBI-1752795;
CC       O43281:EFS; NbExp=1; IntAct=EBI-621482, EBI-718488;
CC       O15371:EIF3D; NbExp=1; IntAct=EBI-621482, EBI-353818;
CC       Q9Y2J2:EPB41L3; NbExp=1; IntAct=EBI-621482, EBI-310986;
CC       O43909:EXTL3; NbExp=1; IntAct=EBI-621482, EBI-1754679;
CC       O00254:F2RL2; NbExp=1; IntAct=EBI-621482, EBI-1751853;
CC       O15360:FANCA; NbExp=1; IntAct=EBI-621482, EBI-81570;
CC       P25445:FAS; NbExp=2; IntAct=EBI-621482, EBI-494743;
CC       P48023:FASLG; NbExp=1; IntAct=EBI-621482, EBI-495538;
CC       P31994:FCGR2B; NbExp=1; IntAct=EBI-621482, EBI-724784;
CC       P31995:FCGR2C; NbExp=1; IntAct=EBI-621482, EBI-1396036;
CC       Q9NZM4:GLTSCR1; NbExp=1; IntAct=EBI-621482, EBI-1754943;
CC       P15586:GNS; NbExp=1; IntAct=EBI-621482, EBI-1752200;
CC       Q9UL51:HCN2; NbExp=1; IntAct=EBI-621482, EBI-1751885;
CC       P31273:HOXC8; NbExp=1; IntAct=EBI-621482, EBI-1752118;
CC       P47928:ID4; NbExp=1; IntAct=EBI-621482, EBI-1754719;
CC       Q9Y6K9:IKBKG; NbExp=1; IntAct=EBI-621482, EBI-81279;
CC       Q9H9L3:ISG20L2; NbExp=1; IntAct=EBI-621482, EBI-751335;
CC       P35968:KDR; NbExp=2; IntAct=EBI-621482, EBI-1005487;
CC       Q07666:KHDRBS1; NbExp=1; IntAct=EBI-621482, EBI-1364;
CC       Q60749:Khdrbs1 (xeno); NbExp=1; IntAct=EBI-621482, EBI-519077;
CC       P49916:LIG3; NbExp=1; IntAct=EBI-621482, EBI-1753381;
CC       Q92918:MAP4K1; NbExp=1; IntAct=EBI-621482, EBI-881;
CC       Q9H204:MED28; NbExp=1; IntAct=EBI-621482, EBI-514199;
CC       Q9NQ76:MEPE; NbExp=1; IntAct=EBI-621482, EBI-1753293;
CC       P46013:MKI67; NbExp=1; IntAct=EBI-621482, EBI-876367;
CC       P43699:NKX2-1; NbExp=1; IntAct=EBI-621482, EBI-1391923;
CC       O95157:NXPH3; NbExp=1; IntAct=EBI-621482, EBI-1752913;
CC       P20774:OGN; NbExp=1; IntAct=EBI-621482, EBI-1753690;
CC       Q9C0H9:P140; NbExp=1; IntAct=EBI-621482, EBI-1393949;
CC       P23760:PAX3; NbExp=1; IntAct=EBI-621482, EBI-1167564;
CC       P23759:PAX7; NbExp=1; IntAct=EBI-621482, EBI-1042757;
CC       Q13087:PDIA2; NbExp=1; IntAct=EBI-621482, EBI-1752525;
CC       P16284:PECAM1; NbExp=1; IntAct=EBI-621482, EBI-716404;
CC       O75167:PHACTR2; NbExp=1; IntAct=EBI-621482, EBI-1754409;
CC       P28340:POLD1; NbExp=1; IntAct=EBI-621482, EBI-716569;
CC       O43900:PRICKLE3; NbExp=1; IntAct=EBI-621482, EBI-1751761;
CC       Q05397:PTK2; NbExp=2; IntAct=EBI-621482, EBI-702142;
CC       Q86X10:RALGAPB; NbExp=1; IntAct=EBI-621482, EBI-1755842;
CC       Q13905:RAPGEF1; NbExp=1; IntAct=EBI-621482, EBI-976876;
CC       Q8TB24:RIN3; NbExp=1; IntAct=EBI-621482, EBI-1570523;
CC       P26373:RPL13; NbExp=1; IntAct=EBI-621482, EBI-356849;
CC       P78345:RPP38; NbExp=1; IntAct=EBI-621482, EBI-366493;
CC       P10301:RRAS; NbExp=1; IntAct=EBI-621482, EBI-968703;
CC       Q9NQC3:RTN4; NbExp=1; IntAct=EBI-621482, EBI-715945;
CC       Q9NZV5:SEPN1; NbExp=1; IntAct=EBI-621482, EBI-1751965;
CC       Q9UPX8:SHANK2; NbExp=1; IntAct=EBI-621482, EBI-1570571;
CC       Q9BYB0:SHANK3; NbExp=1; IntAct=EBI-621482, EBI-1752330;
CC       Q13796:SHROOM2; NbExp=1; IntAct=EBI-621482, EBI-1644065;
CC       Q15036:SNX17; NbExp=1; IntAct=EBI-621482, EBI-1752620;
CC       O60493:SNX3; NbExp=1; IntAct=EBI-621482, EBI-727209;
CC       Q07889:SOS1; NbExp=1; IntAct=EBI-621482, EBI-297487;
CC       Q07890:SOS2; NbExp=1; IntAct=EBI-621482, EBI-298181;
CC       P08047:SP1; NbExp=1; IntAct=EBI-621482, EBI-298336;
CC       Q9QWI6:Srcin1 (xeno); NbExp=1; IntAct=EBI-621482, EBI-775592;
CC       P42227:Stat3 (xeno); NbExp=1; IntAct=EBI-621482, EBI-602878;
CC       Q68CZ2:TNS3; NbExp=11; IntAct=EBI-621482, EBI-1220488;
CC       Q9NRJ4:TULP4; NbExp=1; IntAct=EBI-621482, EBI-1753487;
CC       Q05996:ZP2; NbExp=1; IntAct=EBI-621482, EBI-1755919;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P12931-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P12931-2; Sequence=VSP_012134;
CC   -!- PTM: Phosphorylated on Tyr-530 by c-Src kinase (CSK). The
CC       phosphorylated form is termed pp60c-src. The phosphorylated tail
CC       interacts with the SH2 domain thereby repressing kinase activity.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- SIMILARITY: Contains 1 SH3 domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133293; CAC10573.1; -; Genomic_DNA.
DR   EMBL; AL133293; CAC34523.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76065.1; -; Genomic_DNA.
DR   EMBL; BC011566; AAH11566.1; -; mRNA.
DR   EMBL; BC051270; AAH51270.2; -; mRNA.
DR   EMBL; K03218; AAA60584.1; -; Genomic_DNA.
DR   EMBL; M16237; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; M16243; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; M16244; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; M16245; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; K03212; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; K03213; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; K03214; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; K03215; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; K03216; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; K03217; AAA60584.1; JOINED; Genomic_DNA.
DR   EMBL; X02647; CAA26485.1; -; Genomic_DNA.
DR   EMBL; X03995; CAA26485.1; JOINED; Genomic_DNA.
DR   EMBL; X03996; CAA26485.1; JOINED; Genomic_DNA.
DR   EMBL; X03997; CAA26485.1; JOINED; Genomic_DNA.
DR   EMBL; X03998; CAA26485.1; JOINED; Genomic_DNA.
DR   EMBL; X03999; CAA26485.1; JOINED; Genomic_DNA.
DR   EMBL; X04000; CAA26485.1; JOINED; Genomic_DNA.
DR   IPI; IPI00328867; -.
DR   IPI; IPI00641230; -.
DR   PIR; A26891; TVHUSC.
DR   RefSeq; NP_005408.1; -.
DR   RefSeq; NP_938033.1; -.
DR   UniGene; Hs.195659; -.
DR   PDB; 1A07; X-ray; 2.20 A; A/B=144-249.
DR   PDB; 1A08; X-ray; 2.20 A; A/B=144-249.
DR   PDB; 1A09; X-ray; 2.00 A; A/B=144-249.
DR   PDB; 1A1A; X-ray; 2.00 A; A/B=144-249.
DR   PDB; 1A1B; X-ray; 2.20 A; A/B=144-249.
DR   PDB; 1A1C; X-ray; 2.40 A; A/B=144-249.
DR   PDB; 1A1E; X-ray; 2.20 A; A/B=144-249.
DR   PDB; 1FMK; X-ray; 1.50 A; A=86-536.
DR   PDB; 1HCS; NMR; -; B=144-249.
DR   PDB; 1HCT; NMR; -; B=144-249.
DR   PDB; 1KSW; X-ray; 2.80 A; A=86-535.
DR   PDB; 1O41; X-ray; 1.70 A; A=145-251.
DR   PDB; 1O42; X-ray; 1.70 A; A=145-251.
DR   PDB; 1O43; X-ray; 1.50 A; A=145-251.
DR   PDB; 1O44; X-ray; 1.70 A; A=145-251.
DR   PDB; 1O45; X-ray; 1.80 A; A=145-251.
DR   PDB; 1O46; X-ray; 2.00 A; A=145-251.
DR   PDB; 1O47; X-ray; 1.80 A; A=145-251.
DR   PDB; 1O48; X-ray; 1.55 A; A=145-251.
DR   PDB; 1O49; X-ray; 1.70 A; A=145-251.
DR   PDB; 1O4A; X-ray; 1.50 A; A=145-251.
DR   PDB; 1O4B; X-ray; 1.85 A; A=145-251.
DR   PDB; 1O4C; X-ray; 1.80 A; A=145-251.
DR   PDB; 1O4D; X-ray; 1.85 A; A=145-251.
DR   PDB; 1O4E; X-ray; 2.00 A; A=145-251.
DR   PDB; 1O4F; X-ray; 2.00 A; A=145-251.
DR   PDB; 1O4G; X-ray; 1.55 A; A=145-251.
DR   PDB; 1O4H; X-ray; 2.25 A; A=145-251.
DR   PDB; 1O4I; X-ray; 1.75 A; A=145-251.
DR   PDB; 1O4J; X-ray; 1.70 A; A=145-251.
DR   PDB; 1O4K; X-ray; 1.57 A; A=145-251.
DR   PDB; 1O4L; X-ray; 1.65 A; A=145-251.
DR   PDB; 1O4M; X-ray; 1.60 A; A=145-251.
DR   PDB; 1O4N; X-ray; 1.60 A; A=145-251.
DR   PDB; 1O4O; X-ray; 1.70 A; A=145-251.
DR   PDB; 1O4P; X-ray; 1.90 A; A=145-251.
DR   PDB; 1O4Q; X-ray; 1.70 A; A=145-251.
DR   PDB; 1O4R; X-ray; 1.50 A; A=145-251.
DR   PDB; 1SHD; X-ray; 2.00 A; A=144-248.
DR   PDB; 1Y57; X-ray; 1.91 A; A=86-535.
DR   PDB; 1YI6; X-ray; 2.00 A; A/B=261-535.
DR   PDB; 1YOJ; X-ray; 1.95 A; A/B=254-535.
DR   PDB; 1YOL; X-ray; 2.30 A; A/B=254-535.
DR   PDB; 1YOM; X-ray; 2.90 A; A/B=254-535.
DR   PDB; 2BDF; X-ray; 2.10 A; A/B=258-535.
DR   PDB; 2BDJ; X-ray; 2.50 A; A=258-535.
DR   PDB; 2H8H; X-ray; 2.20 A; A=2-535.
DR   PDB; 2SRC; X-ray; 1.50 A; A=86-535.
DR   PDBsum; 1A07; -.
DR   PDBsum; 1A08; -.
DR   PDBsum; 1A09; -.
DR   PDBsum; 1A1A; -.
DR   PDBsum; 1A1B; -.
DR   PDBsum; 1A1C; -.
DR   PDBsum; 1A1E; -.
DR   PDBsum; 1FMK; -.
DR   PDBsum; 1HCS; -.
DR   PDBsum; 1HCT; -.
DR   PDBsum; 1KSW; -.
DR   PDBsum; 1O41; -.
DR   PDBsum; 1O42; -.
DR   PDBsum; 1O43; -.
DR   PDBsum; 1O44; -.
DR   PDBsum; 1O45; -.
DR   PDBsum; 1O46; -.
DR   PDBsum; 1O47; -.
DR   PDBsum; 1O48; -.
DR   PDBsum; 1O49; -.
DR   PDBsum; 1O4A; -.
DR   PDBsum; 1O4B; -.
DR   PDBsum; 1O4C; -.
DR   PDBsum; 1O4D; -.
DR   PDBsum; 1O4E; -.
DR   PDBsum; 1O4F; -.
DR   PDBsum; 1O4G; -.
DR   PDBsum; 1O4H; -.
DR   PDBsum; 1O4I; -.
DR   PDBsum; 1O4J; -.
DR   PDBsum; 1O4K; -.
DR   PDBsum; 1O4L; -.
DR   PDBsum; 1O4M; -.
DR   PDBsum; 1O4N; -.
DR   PDBsum; 1O4O; -.
DR   PDBsum; 1O4P; -.
DR   PDBsum; 1O4Q; -.
DR   PDBsum; 1O4R; -.
DR   PDBsum; 1SHD; -.
DR   PDBsum; 1Y57; -.
DR   PDBsum; 1YI6; -.
DR   PDBsum; 1YOJ; -.
DR   PDBsum; 1YOL; -.
DR   PDBsum; 1YOM; -.
DR   PDBsum; 2BDF; -.
DR   PDBsum; 2BDJ; -.
DR   PDBsum; 2H8H; -.
DR   PDBsum; 2SRC; -.
DR   ProteinModelPortal; P12931; -.
DR   DIP; DIP-1059N; -.
DR   IntAct; P12931; 131.
DR   MINT; MINT-93621; -.
DR   STRING; P12931; -.
DR   PhosphoSite; P12931; -.
DR   OGP; P12931; -.
DR   PRIDE; P12931; -.
DR   Ensembl; ENST00000358208; ENSP00000350941; ENSG00000197122.
DR   Ensembl; ENST00000373567; ENSP00000362668; ENSG00000197122.
DR   Ensembl; ENST00000373578; ENSP00000362680; ENSG00000197122.
DR   Ensembl; ENST00000445403; ENSP00000408503; ENSG00000197122.
DR   GeneID; 6714; -.
DR   KEGG; hsa:6714; -.
DR   UCSC; uc002xgx.1; human.
DR   CTD; 6714; -.
DR   GeneCards; GC20P035973; -.
DR   H-InvDB; HIX0015793; -.
DR   HGNC; HGNC:11283; SRC.
DR   HPA; CAB004023; -.
DR   MIM; 190090; gene.
DR   PharmGKB; PA36111; -.
DR   eggNOG; prNOG06370; -.
DR   HOVERGEN; HBG008761; -.
DR   OMA; RTETDLS; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Pathway_Interaction_DB; amb2_neutrophils_pathway; amb2 Integrin signaling.
DR   Pathway_Interaction_DB; arf6cyclingpathway; Arf6 signaling events.
DR   Pathway_Interaction_DB; nfkappabatypicalpathway; Atypical NF-kappaB pathway.
DR   Pathway_Interaction_DB; pi3kcipathway; Class I PI3K signaling events.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; epha2_fwdpathway; EPHA2 forward signaling.
DR   Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling.
DR   Pathway_Interaction_DB; ephrinbrevpathway; Ephrin B reverse signaling.
DR   Pathway_Interaction_DB; fgf_pathway; FGF signaling pathway.
DR   Pathway_Interaction_DB; glypican_1pathway; Glypican 1 network.
DR   Pathway_Interaction_DB; avb3_integrin_pathway; Integrins in angiogenesis.
DR   Pathway_Interaction_DB; lysophospholipid_pathway; LPA receptor mediated events.
DR   Pathway_Interaction_DB; a4b1_paxindep_pathway; Paxillin-independent events mediated by a4b1 and a4b7.
DR   Pathway_Interaction_DB; pdgfrbpathway; PDGFR-beta signaling pathway.
DR   Pathway_Interaction_DB; er_nongenomic_pathway; Plasma membrane estrogen receptor signaling.
DR   Pathway_Interaction_DB; ar_tf_pathway; Regulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; s1p_s1p3_pathway; S1P3 pathway.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; prlsignalingeventspathway; Signaling events mediated by PRL.
DR   Pathway_Interaction_DB; ptp1bpathway; Signaling events mediated by PTP1B.
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; ret_pathway; Signaling events regulated by Ret tyrosine kinase.
DR   Pathway_Interaction_DB; syndecan_2_pathway; Syndecan-2-mediated signaling events.
DR   Pathway_Interaction_DB; syndecan_3_pathway; Syndecan-3-mediated signaling events.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_11123; Membrane Trafficking.
DR   Reactome; REACT_13552; Integrin cell surface interactions.
DR   Reactome; REACT_16888; Signaling by PDGF.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   Reactome; REACT_9417; Signaling by EGFR.
DR   Reactome; REACT_9470; Signaling by FGFR.
DR   DrugBank; DB01254; Dasatinib.
DR   NextBio; 26186; -.
DR   PMAP-CutDB; P12931; -.
DR   ArrayExpress; P12931; -.
DR   Bgee; P12931; -.
DR   CleanEx; HS_SRC; -.
DR   Genevestigator; P12931; -.
DR   GermOnline; ENSG00000197122; Homo sapiens.
DR   GO; GO:0005901; C:caveola; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005178; F:integrin binding; TAS:BHF-UCL.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; TAS:BHF-UCL.
DR   GO; GO:0042169; F:SH2 domain binding; IPI:UniProtKB.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:BHF-UCL.
DR   GO; GO:0033625; P:positive regulation of integrin activation; TAS:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007265; P:Ras protein signal transduction; EXP:Reactome.
DR   GO; GO:0045124; P:regulation of bone resorption; TAS:BHF-UCL.
DR   GO; GO:0043114; P:regulation of vascular permeability; TAS:BHF-UCL.
DR   GO; GO:0070555; P:response to interleukin-1; IMP:BHF-UCL.
DR   GO; GO:0007172; P:signal complex assembly; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR020744; Tyr_kinase_non-rcpt_Src.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF255; Tyr_kinase_non-rcpt_Src; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50044; SH3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Host-virus interaction; Kinase; Lipoprotein; Myristate;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   SH2 domain; SH3 domain; Transferase; Tyrosine-protein kinase.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    536       Proto-oncogene tyrosine-protein kinase
FT                                Src.
FT                                /FTId=PRO_0000088141.
FT   DOMAIN       84    145       SH3.
FT   DOMAIN      151    248       SH2.
FT   DOMAIN      270    523       Protein kinase.
FT   NP_BIND     276    284       ATP.
FT   ACT_SITE    389    389       Proton acceptor.
FT   BINDING     298    298       ATP.
FT   MOD_RES      17     17       Phosphoserine.
FT   MOD_RES      35     35       Phosphoserine.
FT   MOD_RES      69     69       Phosphoserine.
FT   MOD_RES      74     74       Phosphothreonine.
FT   MOD_RES      75     75       Phosphoserine.
FT   MOD_RES     187    187       Phosphotyrosine (By similarity).
FT   MOD_RES     419    419       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     439    439       Phosphotyrosine.
FT   MOD_RES     511    511       Phosphothreonine.
FT   MOD_RES     522    522       Phosphotyrosine.
FT   MOD_RES     530    530       Phosphotyrosine; by CSK.
FT   LIPID         2      2       N-myristoyl glycine (By similarity).
FT   VAR_SEQ     117    117       T -> TRKVDVR (in isoform 2).
FT                                /FTId=VSP_012134.
FT   VARIANT     176    176       L -> F (in dbSNP:rs6018260).
FT                                /FTId=VAR_051699.
FT   VARIANT     237    237       A -> T (in dbSNP:rs34881773).
FT                                /FTId=VAR_041830.
FT   STRAND       87     93
FT   STRAND       99    102
FT   STRAND      110    114
FT   STRAND      118    126
FT   TURN        127    129
FT   STRAND      132    136
FT   HELIX       137    139
FT   STRAND      140    142
FT   HELIX       146    148
FT   HELIX       158    165
FT   STRAND      174    179
FT   STRAND      181    183
FT   STRAND      187    195
FT   TURN        196    198
FT   STRAND      199    209
FT   STRAND      215    218
FT   STRAND      221    225
FT   HELIX       226    235
FT   STRAND      240    242
FT   STRAND      256    259
FT   HELIX       267    269
FT   STRAND      270    278
FT   STRAND      283    289
FT   TURN        290    292
FT   STRAND      293    299
FT   HELIX       307    319
FT   STRAND      328    332
FT   STRAND      334    336
FT   STRAND      338    341
FT   HELIX       349    353
FT   HELIX       355    358
FT   HELIX       363    382
FT   HELIX       392    394
FT   STRAND      395    397
FT   HELIX       399    401
FT   STRAND      403    405
FT   HELIX       429    431
FT   HELIX       434    439
FT   HELIX       444    459
FT   TURN        460    462
FT   HELIX       471    479
FT   HELIX       492    501
FT   HELIX       506    508
FT   HELIX       512    520
FT   TURN        521    523
SQ   SEQUENCE   536 AA;  59835 MW;  C1908084683E5DE8 CRC64;
     MGSNKSKPKD ASQRRRSLEP AENVHGAGGG AFPASQTPSK PASADGHRGP SAAFAPAAAE
     PKLFGGFNSS DTVTSPQRAG PLAGGVTTFV ALYDYESRTE TDLSFKKGER LQIVNNTEGD
     WWLAHSLSTG QTGYIPSNYV APSDSIQAEE WYFGKITRRE SERLLLNAEN PRGTFLVRES
     ETTKGAYCLS VSDFDNAKGL NVKHYKIRKL DSGGFYITSR TQFNSLQQLV AYYSKHADGL
     CHRLTTVCPT SKPQTQGLAK DAWEIPRESL RLEVKLGQGC FGEVWMGTWN GTTRVAIKTL
     KPGTMSPEAF LQEAQVMKKL RHEKLVQLYA VVSEEPIYIV TEYMSKGSLL DFLKGETGKY
     LRLPQLVDMA AQIASGMAYV ERMNYVHRDL RAANILVGEN LVCKVADFGL ARLIEDNEYT
     ARQGAKFPIK WTAPEAALYG RFTIKSDVWS FGILLTELTT KGRVPYPGMV NREVLDQVER
     GYRMPCPPEC PESLHDLMCQ CWRKEPEERP TFEYLQAFLE DYFTSTEPQY QPGENL
//
